{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:21Z","timestamp":1761895821131,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.diabres.2014.01.030","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T04:16:13Z","timestamp":1392092173000},"page":"234-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Significant association of poor glycemic control with increased resistance in efferent arterioles \u2013 Study of inulin and para-aminohippuric acid clearance in humans"],"prefix":"10.1016","volume":"104","author":[{"given":"A.","family":"Tsuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ichii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0099-1161","authenticated-orcid":false,"given":"S.","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2014.01.030_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2008.10.005","article-title":"United States renal data system 2008 annual data report","volume":"53","author":"Collins","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2014.01.030_bib0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncpneph0298","article-title":"Hypertension and antihypertensive treatment of diabetic nephropathy","volume":"2","author":"Ritz","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.01.030_bib0020","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/ndt\/gfn377","article-title":"Activation of the renal renin-angiotensin system in diabetes \u2013 new concepts","volume":"23","author":"Peti-Peterdi","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2014.01.030_bib0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1523-1755.2004.00848.x","article-title":"C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress","volume":"66","author":"Lewko","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.01.030_bib0030","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/ndt\/gfg263","article-title":"The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy","volume":"18","author":"Arima","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2014.01.030_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/0705-MR-134","article-title":"Diabetic nephropathy: mechanisms of renal disease progression","volume":"233","author":"Kanwar","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.diabres.2014.01.030_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0045","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI102534","article-title":"Evaluation of renal resistances, with special reference to changes in essential hypertension","volume":"30","author":"Gomez","year":"1951","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2014.01.030_bib0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0895-7061(00)01238-3","article-title":"Effect of familial hypertension on glomerular hemodynamics and tubulo-glomerular feedback after uninephrectomy","volume":"14","author":"Guidi","year":"2001","journal-title":"Am J Hypertens"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2014.01.030_bib0055","first-page":"S67","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.01.030_bib0060","first-page":"871","article-title":"Dietary recommendations for chronic kidney disease, 2007","volume":"49","author":"Nakao","year":"2007","journal-title":"Nihon Jinzo Gakkai Shi"},{"year":"2007","series-title":"Treatment guide for diabetes","key":"10.1016\/j.diabres.2014.01.030_bib0065"},{"key":"10.1016\/j.diabres.2014.01.030_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10157-008-0084-z","article-title":"Simple sampling strategy for measuring inulin renal clearance","volume":"13","author":"Horio","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/EJE-13-0026","article-title":"Relationship between serum TSH levels and intrarenal hemodynamic parameters in euthyroid subjects","volume":"169","author":"Tsuda","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0080","article-title":"Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients","author":"Tsuda","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.01.030_bib0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10157-009-0174-6","article-title":"Evaluation of a new automated, enzymatic inulin assay using d-fructose dehydrogenase","volume":"13","author":"Kimata","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0090","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1681\/ASN.V11112001","article-title":"Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions","volume":"11","author":"Fliser","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0095","first-page":"R978","article-title":"Fallacy of indexing renal and systemic hemodynamic measurements for body surface area","volume":"268","author":"Turner","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.trsl.2007.07.001","article-title":"Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats","volume":"150","author":"Komers","year":"2007","journal-title":"Transl Res"},{"key":"10.1016\/j.diabres.2014.01.030_bib0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-9343(82)90490-9","article-title":"The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies","volume":"72","author":"Hostetter","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2014.01.030_bib0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00041552-200003000-00012","article-title":"Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?","volume":"9","author":"Komers","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.diabres.2014.01.030_bib0115","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1681\/ASN.V2111578","article-title":"Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements","volume":"2","author":"Hayashi","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0120","doi-asserted-by":"crossref","first-page":"F1039","DOI":"10.1152\/ajprenal.00371.2003","article-title":"High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells","volume":"286","author":"Vidotti","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0125","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ki.1987.100","article-title":"Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics","volume":"31","author":"Wiseman","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.01.030_bib0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0891-6632(91)90049-U","article-title":"Comparison of renal hemodynamics in early non-insulin-dependent and insulin-dependent diabetes mellitus","volume":"5","author":"Ishida","year":"1991","journal-title":"J Diabet Complications"},{"key":"10.1016\/j.diabres.2014.01.030_bib0135","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1681\/ASN.V1081778","article-title":"Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus","volume":"10","author":"Miller","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0140","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1046\/j.1523-1755.2000.07715.x","article-title":"Role of angiotensin II in diabetic nephropathy","volume":"77","author":"Leehey","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.diabres.2014.01.030_bib0145","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1159\/000320593","article-title":"High glucose upregulates upstream stimulatory factor 2 in human renal proximal tubular cells through angiotensin II-dependent activation of CREB","volume":"117","author":"Visavadiya","year":"2011","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0150","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/01.ASN.0000026610.48842.CB","article-title":"Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition","volume":"13","author":"Nishiyama","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0155","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.ASN.0000060804.40201.6E","article-title":"Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose","volume":"14","author":"Singh","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0160","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1152\/ajpregu.00027.2010","article-title":"Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus","volume":"299","author":"Cherney","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.diabres.2014.01.030_bib0165","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s00125-007-0795-9","article-title":"Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats","volume":"50","author":"Kelly","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2014.01.030_bib0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.107.108845","article-title":"Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats","volume":"52","author":"Feldman","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.diabres.2014.01.030_bib0175","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.01.030_bib0180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000024416.33113.0A","article-title":"Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect","volume":"106","author":"Viberti","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2014.01.030_bib0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/clc.4960280307","article-title":"Losartan and end-organ protection-lessons from the RENAAL study","volume":"28","author":"Kowey","year":"2005","journal-title":"Clin Cardiol"},{"issue":"Suppl. 3","key":"10.1016\/j.diabres.2014.01.030_bib0190","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1097\/01.ASN.0000032544.37147.AE","article-title":"Renal and cardiovascular protection in type 2 diabetes mellitus: angiotensin II receptor blockers","volume":"13","author":"Deferrari","year":"2002","journal-title":"J Am Soc Nephrol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882271400062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882271400062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T07:01:12Z","timestamp":1648278072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882271400062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S016882271400062X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2014.01.030","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant association of poor glycemic control with increased resistance in efferent arterioles \u2013 Study of inulin and para-aminohippuric acid clearance in humans","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2014.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}